Clinical Trials · NCT04909333
Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- University Hospital, Basel, Switzerland
- Enrollment
- 29
- Start date
- Apr 2021
- Locations
- 1 site, Switzerland
- Primary endpoint
- time to symptomatic hypoglycemia after exenatide test compared to placebo